Continuing Single-Agent Bevacizumab as Maintenance Therapy After Induction XELOX (or FOLFOX) Plus Bevacizumab in First-Line Treatment of Metastatic Colorectal Cancer

Por Díaz-Rubio, Eduardo, Pietrantonio, Filippo, de Braud, Filippo
Publicado em 2012

Chemotherapy for gastric cancer

Por Sastre, Javier, García-Saenz, Jose Angel, Díaz-Rubio, Eduardo
Publicado em 2006

Role of cetuximab in first-line treatment of metastatic colorectal cancer

Por Sotelo, Miguel Jhonatan, García-Paredes, Beatriz, Aguado, Carlos, Sastre, Javier, Díaz-Rubio, Eduardo
Publicado em 2014

Should capecitabine replace 5-fluorouracil in the first-line treatment of metastatic colorectal cancer?

Por Aguado, Carlos, García-Paredes, Beatriz, Sotelo, Miguel Jhonatan, Sastre, Javier, Díaz-Rubio, Eduardo
Publicado em 2014

Frequency and Variability of Genomic Rearrangements on MSH2 in Spanish Lynch Syndrome Families

Por Romero, Atocha, Garre, Pilar, Valentin, Olivia, Sanz, Julian, Pérez-Segura, Pedro, Llovet, Patricia, Díaz-Rubio, Eduardo, de la Hoya, Miguel, Caldés, Trinidad
Publicado em 2013

Telomere function in colorectal cancer

Por Frías, Cristina, Morán, Alberto, de Juan, Carmen, Ortega, Paloma, Fernández-Marcelo, Tamara, Sánchez-Pernaute, Andrés, Torres, Antonio José, Díaz-Rubio, Eduardo, Benito, Manuel, Iniesta, Pilar
Publicado em 2009

Differential colorectal carcinogenesis: Molecular basis and clinical relevance

Por Morán, Alberto, Ortega, Paloma, de Juan, Carmen, Fernández-Marcelo, Tamara, Frías, Cristina, Sánchez-Pernaute, Andrés, Torres, Antonio José, Díaz-Rubio, Eduardo, Iniesta, Pilar, Benito, Manuel
Publicado em 2010

First-Line Cetuximab Plus Capecitabine in Elderly Patients with Advanced Colorectal Cancer: Clinical Outcome and Subgroup Analysis According to KRAS Status from a Spanish TTD Group...

Por Sastre, Javier, Grávalos, Cristina, Rivera, Fernando, Massuti, Bartomeu, Valladares-Ayerbes, Manuel, Marcuello, Eugenio, Manzano, José L., Benavides, Manuel, Hidalgo, Manuel, Díaz-Rubio, Eduardo, Aranda, Enrique
Publicado em 2012

Low prevalence of germline hMSH6 mutations in colorectal cancer families from Spain

Por de Abajo, Ana Sánchez, de la Hoya, Miguel, Tosar, Alicia, Godino, Javier, Fernández, Juan Manuel, Asenjo, Jose Lopez, Villamil, Beatriz Perez, Segura, Pedro Perez, Diaz-Rubio, Eduardo, Caldes, Trinidad
Publicado no World J Gastroenterol (2005)

Poly (ADP-ribose) polymerase 3 (PARP3), a potential repressor of telomerase activity

Por Fernández-Marcelo, Tamara, Frías, Cristina, Pascua, Irene, de Juan, Carmen, Head, Jacqueline, Gómez, Ana, Hernando, Florentino, Jarabo, Jose-Ramon, Díaz-Rubio, Eduardo, Torres, Antonio-Jose, Rouleau, Michèle, Benito, Manuel, Iniesta, Pilar
Publicado em 2014

Low prevalence of SLX4 loss-of-function mutations in non-BRCA1/2 breast and/or ovarian cancer families

Por de Garibay, Gorka Ruiz, Díaz, Avellaneda, Gaviña, Belén, Romero, Atocha, Garre, Pilar, Vega, Ana, Blanco, Ana, Tosar, Alicia, Díez, Orland, Pérez-Segura, Pedro, Díaz-Rubio, Eduardo, Caldés, Trinidad, de la Hoya, Miguel
Publicado em 2013

Tumor burden monitoring using cell-free tumor DNA could be limited by tumor heterogeneity in advanced breast cancer and should be evaluated together with radiographic imaging

Por García-Saenz, José Angel, Ayllón, Patricia, Laig, Marion, Acosta-Eyzaguirre, Daniel, García-Esquinas, Marta, Montes, Myriam, Sanz, Julián, Barquín, Miguel, Moreno, Fernando, Garcia-Barberan, Vanesa, Díaz-Rubio, Eduardo, Caldes, Trinidad, Romero, Atocha
Publicado no BMC Cancer (2017)

BRCA1 Alternative splicing landscape in breast tissue samples

Por Romero, Atocha, García-García, Francisco, López-Perolio, Irene, Ruiz de Garibay, Gorka, García-Sáenz, José A, Garre, Pilar, Ayllón, Patricia, Benito, Esperanza, Dopazo, Joaquín, Díaz-Rubio, Eduardo, Caldés, Trinidad, de la Hoya, Miguel
Publicado no BMC Cancer (2015)

Colon cancer molecular subtypes identified by expression profiling and associated to stroma, mucinous type and different clinical behavior

Por Perez Villamil, Beatriz, Romera Lopez, Alejandro, Hernandez Prieto, Susana, Lopez Campos, Guillermo, Calles, Antonio, Lopez Asenjo, Jose Antonio, Sanz Ortega, Julian, Fernandez Perez, Cristina, Sastre, Javier, Alfonso, Rosario, Caldes, Trinidad, Martin Sanchez, Fernando, Diaz Rubio, Eduardo
Publicado em 2012

Assessment of Topoisomerase II α Status in Breast Cancer by Quantitative PCR, Gene Expression Microarrays, Immunohistochemistry, and Fluorescence in Situ Hybridization

Por Romero, Atocha, Martín, Miguel, Cheang, Maggie C.U., López García-Asenjo, José Antonio, Oliva, Belén, He, Xiaping, de la Hoya, Miguel, García Sáenz, Jose Ángel, Arroyo Fernández, Manuel, Díaz Rubio, Eduardo, Perou, Charles M., Llopis, Trinidad Caldés
Publicado em 2011

Circulating Tumor Cell Count Is a Prognostic Factor in Metastatic Colorectal Cancer Patients Receiving First-Line Chemotherapy Plus Bevacizumab: A Spanish Cooperative Group for the...

Por Sastre, Javier, Maestro, M. Luisa, Gómez-España, Auxiliadora, Rivera, Fernando, Valladares, Manuel, Massuti, Bartomeu, Benavides, Manuel, Gallén, Manuel, Marcuello, Eugenio, Abad, Albert, Arrivi, Antonio, Fernández-Martos, Carlos, González, Encarnación, Tabernero, Josep M., Vidaurreta, Marta, Aranda, Enrique, Díaz-Rubio, Eduardo
Publicado em 2012

Role of Kras Status in Patients with Metastatic Colorectal Cancer Receiving First-Line Chemotherapy plus Bevacizumab: A TTD Group Cooperative Study

Por Díaz-Rubio, Eduardo, Gómez-España, Auxiliadora, Massutí, Bartomeu, Sastre, Javier, Reboredo, Margarita, Manzano, José Luis, Rivera, Fernando, Safont, MªJosé, Montagut, Clara, González, Encarnación, Benavides, Manuel, Marcuello, Eugenio, Cervantes, Andrés, Martínez de Prado, Purificación, Fernández-Martos, Carlos, Arrivi, Antonio, Bando, Inmaculada
Publicado em 2012

Circulating Tumor Cells Following First Chemotherapy Cycle: An Early and Strong Predictor of Outcome in Patients With Metastatic Breast Cancer

Por Martín, Miguel, Custodio, Sara, de las Casas, Maria-Luisa Maestro, García-Sáenz, José-Ángel, de la Torre, Julio-César, Bellón-Cano, Jose-María, López-Tarruella, Sara, Vidaurreta-Lazaro, Marta, de la Orden, Virginia, Jerez, Yolanda, Márquez-Rodas, Iván, Casado, Antonio, Sastre, Javier, Díaz-Rubio, Eduardo
Publicado em 2013

First-Line XELOX Plus Bevacizumab Followed by XELOX Plus Bevacizumab or Single-Agent Bevacizumab as Maintenance Therapy in Patients with Metastatic Colorectal Cancer: The Phase III...

Por Díaz-Rubio, Eduardo, Gómez-España, Auxiliadora, Massutí, Bartomeu, Sastre, Javier, Abad, Albert, Valladares, Manuel, Rivera, Fernando, Safont, Maria J., Martínez de Prado, Purificación, Gallén, Manuel, González, Encarnación, Marcuello, Eugenio, Benavides, Manuel, Fernández-Martos, Carlos, Losa, Ferrán, Escudero, Pilar, Arrivi, Antonio, Cervantes, Andrés, Dueñas, Rosario, López-Ladrón, Amelia, Lacasta, Adelaida, Llanos, Marta, Tabernero, Jose M., Antón, Antonio, Aranda, Enrique
Publicado em 2012

Body Mass Index Is Prognostic in Metastatic Colorectal Cancer: Pooled Analysis of Patients From First-Line Clinical Trials in the ARCAD Database

Por Renfro, Lindsay A., Loupakis, Fotios, Adams, Richard A., Seymour, Matthew T., Heinemann, Volker, Schmoll, Hans-Joachim, Douillard, Jean-Yves, Hurwitz, Herbert, Fuchs, Charles S., Diaz-Rubio, Eduardo, Porschen, Rainer, Tournigand, Christophe, Chibaudel, Benoist, Falcone, Alfredo, Tebbutt, Niall C., Punt, Cornelis J.A., Hecht, J. Randolph, Bokemeyer, Carsten, Van Cutsem, Eric, Goldberg, Richard M., Saltz, Leonard B., de Gramont, Aimery, Sargent, Daniel J., Lenz, Heinz-Josef
Publicado no J Clin Oncol (2016)